Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F20%3A00559752" target="_blank" >RIV/68378050:_____/20:00559752 - isvavai.cz</a>
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/10.1002/eji.201948357" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/eji.201948357</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/eji.201948357" target="_blank" >10.1002/eji.201948357</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting
Popis výsledku v původním jazyce
Secondary diversification of the Ig repertoire occurs through somatic hypermutation (SHM), gene conversion (GCV), and class switch recombination (CSR)-three processes that are initiated by activation-induced cytidine deaminase (AID). AID targets Ig genes at orders of magnitude higher than the rest of the genome, but the basis for this specificity is poorly understood. We have previously demonstrated that enhancers and enhancer-like sequences from Ig genes are capable of stimulating SHM of neighboring genes in a capacity distinct from their roles in increasing transcription. Here, we use an in vitro proteomics approach to identify E-box, MEF2, Ets, and Ikaros transcription factor family members as potential binders of these enhancers. ChIP assays in the hypermutating Ramos B cell line confirmed that many of these factors bound the endogenous Ig lambda enhancer and/or the IgH intronic enhancer (E mu) in vivo. Further investigation using SHM reporter assays identified binding sites for E2A and MEF2B in E mu and demonstrated an association between loss of factor binding and decreases in the SHM stimulating activity of E mu mutants. Our results provide novel insights into trans-acting factors that dictate SHM targeting and link their activity to specific DNA binding sites within Ig enhancers.
Název v anglickém jazyce
Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting
Popis výsledku anglicky
Secondary diversification of the Ig repertoire occurs through somatic hypermutation (SHM), gene conversion (GCV), and class switch recombination (CSR)-three processes that are initiated by activation-induced cytidine deaminase (AID). AID targets Ig genes at orders of magnitude higher than the rest of the genome, but the basis for this specificity is poorly understood. We have previously demonstrated that enhancers and enhancer-like sequences from Ig genes are capable of stimulating SHM of neighboring genes in a capacity distinct from their roles in increasing transcription. Here, we use an in vitro proteomics approach to identify E-box, MEF2, Ets, and Ikaros transcription factor family members as potential binders of these enhancers. ChIP assays in the hypermutating Ramos B cell line confirmed that many of these factors bound the endogenous Ig lambda enhancer and/or the IgH intronic enhancer (E mu) in vivo. Further investigation using SHM reporter assays identified binding sites for E2A and MEF2B in E mu and demonstrated an association between loss of factor binding and decreases in the SHM stimulating activity of E mu mutants. Our results provide novel insights into trans-acting factors that dictate SHM targeting and link their activity to specific DNA binding sites within Ig enhancers.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30102 - Immunology
Návaznosti výsledku
Projekt
<a href="/cs/project/GA15-24776S" target="_blank" >GA15-24776S: Chybné cílení somatických hypermutací a jeho vliv na nestabilitu genomu B lymfocytů</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Journal of Immunology
ISSN
0014-2980
e-ISSN
1521-4141
Svazek periodika
50
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
DE - Spolková republika Německo
Počet stran výsledku
16
Strana od-do
380-395
Kód UT WoS článku
000503430500001
EID výsledku v databázi Scopus
—